Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0D5GD
|
||||
| Former ID |
DIB013065
|
||||
| Drug Name |
Flumazenil
|
||||
| Synonyms |
FlumUP TD; Flumazenil (transdermal patch formulation); Flumazenil (transdermal patch formulation), Coeruleus
|
||||
| Drug Type |
Small molecular drug
|
||||
| Company |
Coeruleus Ltd
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C15H14FN3O3
|
||||
| InChI |
InChI=1S/C15H14FN3O3/c1-3-22-15(21)13-12-7-18(2)14(20)10-6-9(16)4-5-11(10)19(12)8-17-13/h4-6,8H,3,7H2,1-2H3
|
||||
| InChIKey |
OFBIFZUFASYYRE-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID |
10027, 5337218, 7847762, 7849653, 7979237, 8152147, 11111184, 11114035, 11532958, 12013048, 14849666, 17405069, 22391550, 24278437, 26719655, 26752172, 26752173, 29222508, 46386776, 46487948, 46507438, 47216937, 47216938, 47662473, 48035311, 48110620, 48416023, 49835190, 49978813, 50104818, 50104819, 50139275, 53777612, 56422177, 56464700, 56464701, 57321761, 58106963, 79129620, 80953768, 81065484, 85231047, 85788338, 90341071, 92303871, 92308307, 92308711, 92714603, 93166924, 99233261
|
||||
| Target and Pathway | |||||
| Target(s) | Peripheral-type benzodiazepine receptor | Target Info | Antagonist | [543743] | |
| KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
| HTLV-I infection | |||||
| References | |||||
| Ref 467528 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4192). | ||||
| Ref 522823 | ClinicalTrials.gov (NCT00997087) A Randomized, Double-Blind, Placebo-Controlled Trial of Flumazenil for the Treatment of Obsessive Compulsive Disorder. U.S. National Institutes of Health. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.